Matthews Asia Dividend Active ETF ADVE 深 滬
等待開盤 12-12 09:30:00 美东时间
39.3073
-0.092
-0.23%
華盛通- 最 高39.34
- 今 開39.285
- 成交量 3234股
- 最 低 39.185
- 昨 收 39.3993
- 總市值 393.07万
- 52周最高 39.74
- 市盈率 靜 --
- 換手率 3.23%
- 52周最低 26.6143
- 委 比 0.00%
- 總股本 10.00万
- 歷史最高 39.74
- 量 比 2.73
- 振 幅 0.39%
- 歷史最低 26.0215
- 每 手 1
- 風險率 2.97%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK Ab+ gMG THOUSAND OAKS, C...
今天 07:09
ROYAL CARIBBEAN EXPANDS SEASONAL LINEUP OF 2027-28 CARIBBEAN ADVENTURES
The vacation brand will deliver tropical getaways for every season from Florida, New Orleans and the Caribbean, including adventures on Legend of the Seas and the amplified Allure of the Sea...
12-10 00:00
Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US
Ready-to-use sepsis therapy marks new advancement in time-critical treatment LONDON, Dec. 8, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company,...
12-09 05:13
Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration
Leading edge artificial intelligence and machine learning platform supports enhanced salesforce targeting and engagement for cutaneous T-cell lymphoma immunotherapy launch CRANFORD, N.J., No...
11-21 21:37
Give Your Back a Break this Holiday with The Joint Chiropractic's "Back Friday Deals"
SCOTTSDALE, Ariz., Nov. 17, 2025 /PRNewswire/ -- The holidays can feel like a full-contact sport for your back. Gift bags, decorations, family gatherings and endless to-do lists all add up, ...
11-18 02:30
ROYAL CARIBBEAN OPENS NEW CARIBBEAN ADVENTURES FOR 2027-28
The year-round lineup from Florida includes visits to top-rated destinations on Star and Harmony of the Seas, plus Oasis Class game-changing ships sailing short getaways MIAMI, Nov. 4, 2025 ...
11-05 00:03
Lilly to Acquire Adverum Biotechnologies
Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose Acquisition ali...
10-24 20:30
ROYAL CARIBBEAN REVEALS SUMMER 2027 ADVENTURES TO ALASKA
Vacationers are in for an action-packed lineup from Anthem of the Seas and its first-ever Cruisetour experiences to more ways to explore on Quantum, Serenade and Voyager of the Seas MIAMI, O...
10-22 23:34
OUTFRONT and AWS USHER IN A NEW ERA FOR OUT-OF-HOME ADVERTISING
Marks a Major Step Toward Digitizing and Automating OOH with AI-Enabled Workflows NEW YORK, Oct. 15, 2025 /PRNewswire/ -- In a significant industry development, OUTFRONT Media Inc. (NYSE: OU...
10-15 21:25
RTX's Advanced Electronic Warfare prototype for F/A-18E/F Super Hornet passes critical review
New technology will accelerate advanced capability for the Navy's primary Strike Fighter PATUXENT RIVER, Md., Sept. 22, 2025 /PRNewswire/ -- Raytheon, an RTX (NYSE: RTX) business, has succes...
09-22 21:00
